PE20001564A1 - 1,3-dioxepin-5-ona con un anillo de 7 miembros como inhibidores de proteasas - Google Patents

1,3-dioxepin-5-ona con un anillo de 7 miembros como inhibidores de proteasas

Info

Publication number
PE20001564A1
PE20001564A1 PE2000000226A PE0002262000A PE20001564A1 PE 20001564 A1 PE20001564 A1 PE 20001564A1 PE 2000000226 A PE2000000226 A PE 2000000226A PE 0002262000 A PE0002262000 A PE 0002262000A PE 20001564 A1 PE20001564 A1 PE 20001564A1
Authority
PE
Peru
Prior art keywords
alkyl
dioxepin
ona
het
alkenyl
Prior art date
Application number
PE2000000226A
Other languages
English (en)
Inventor
Stacie Marie Halbert
Scott Kevin Thompson
Daniel Frank Veber
Sirishkumar Nidamarthy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE20001564A1 publication Critical patent/PE20001564A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A 1,3-DIOXEPIN-5-ONA CON UN ANILLO DE 7 MIEMBROS DE FORMULA I, DONDE: R1-R8, R11, R16, R17, R` SON H, ALQUILO C1-C6, ALQUENILO C2-C6, ALQUINILO C2-C6, Ar-ALQUILO C0-C6, HET-ALQUILO C0-C6; R9 ES ALQUILO C3-C6, Ar, HET, CH(R10)Ar, CH(R10)OAr, NR10R11, CH(R10)NR11R12; R10 ES H, ALQUENILO C2-C6, ALQUINILO C2-C6, CICLOALQUIL C3-C11-ALQUILO C0-C6, Ar-ALQUILO C0-C6, Ar-ALQUENILO C2-C6, OPCIONALMENTE SUSTITUIDO CON OR13, SR13, NR13R14, N(R')CO2R', ENTRE OTROS; R12 ES R15, R15C(O), R15C(S), R15OC(O), R15OC(O)NR11CH(R10)(CO); R13 Y R14 SON H, ALQUILO C1-C6, ALQUENILO C2-C6, Ar-ALQUILO C0-C6, HET-ALQUILO C0-C6, R16R17N-ALQUILO C2-C6; R15 ES ALQUILO C1-C6, ALQUENILO C2-C6, Ar-ALQUILO C0-C6, HET-ALQUILO C0-C6; Ar ES FENILO, NAFTILO OPCIONALMENTE SUSTITUIDO CON Ph-ALQUILO C0-C6, HET-ALQUILO C0-C6, ALQUILO C1-C6, NR13R14, ENTRE OTROS. SON COMPUESTOS PREFERIDOS (6-RS)-6-[N-(N-BENZOFURAN-2-OIL-L-LEUCINIL)AMINO]-1,3-DIOXEPIN-5-ONA, (6-RS)-6-[N-[N-(5,6-DIMETOXIBENZOFURAN-2-OIL-L-LEUCINIL]-AMINO]-1,3-DIOXEPIN-5-ONA, (6RS)-6[N-[N-(N-BENZOTIOFEN-2-OIL-L-LEUCINIL)AMINO]-1,3-DIOXEPIN-5-ONA, ENTRE OTROS. EL COMPUESTO I ES UN INHIBIDOR DE PROTEASAS DE PREFERENCIA CISTEINA O SERINA PROTEASAS Y PUEDE SER UTIL PARA EL TRATAMIENTO DE UNA ENFERMEDAD CARACTERIZADA POR PERDIDA OSEA, OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, ARTRITIS REUMATOIDE
PE2000000226A 1999-03-16 2000-03-16 1,3-dioxepin-5-ona con un anillo de 7 miembros como inhibidores de proteasas PE20001564A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12465999P 1999-03-16 1999-03-16

Publications (1)

Publication Number Publication Date
PE20001564A1 true PE20001564A1 (es) 2001-02-08

Family

ID=22416114

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000226A PE20001564A1 (es) 1999-03-16 2000-03-16 1,3-dioxepin-5-ona con un anillo de 7 miembros como inhibidores de proteasas

Country Status (9)

Country Link
EP (1) EP1161237A4 (es)
JP (1) JP2002539160A (es)
AR (1) AR022927A1 (es)
AU (1) AU3888200A (es)
CO (1) CO5180542A1 (es)
HK (1) HK1043534A1 (es)
PE (1) PE20001564A1 (es)
UY (1) UY26026A1 (es)
WO (1) WO2000054769A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
AU1588901A (en) 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
JP2003513972A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
JP2003513924A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
SK13632002A3 (sk) 2000-03-21 2003-02-04 Smithkline Beecham Corporation C1-6-alkyl-4-amino-azepán-3-ónové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukty
WO2003062192A1 (en) 2002-01-17 2003-07-31 Smithkline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
JP2004196696A (ja) * 2002-12-18 2004-07-15 Kyowa Hakko Kogyo Co Ltd 関節炎の予防剤または治療剤
DK2714675T3 (en) * 2011-05-27 2019-04-15 Lexicon Pharmaceuticals Inc 4H-Thieno [3,2-c] chromium-based inhibitors of notum pectin acetyl esterase and methods for their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374623A (en) * 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use
DE69321087T2 (de) * 1992-12-25 1999-05-20 Mitsubishi Chem Corp Alpha-aminoketon Derivate

Also Published As

Publication number Publication date
EP1161237A1 (en) 2001-12-12
CO5180542A1 (es) 2002-07-30
WO2000054769A1 (en) 2000-09-21
EP1161237A4 (en) 2002-03-27
UY26026A1 (es) 2000-10-31
HK1043534A1 (zh) 2002-09-20
AR022927A1 (es) 2002-09-04
JP2002539160A (ja) 2002-11-19
AU3888200A (en) 2000-10-04

Similar Documents

Publication Publication Date Title
RS20080517A (en) Lactam containing compounds and derivatives thereof as factor xa inhibitors
PE20021005A1 (es) Quinazolinas como inhibidores de mmp-13
BG106013A (en) New compounds and compositions as protease inhibitors
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
EE200200132A (et) Uudsed spiroheterotsüklilised ühendid, mis on kasulikud tsüsteiinproteaaside pöörduvate inhibiitoritena
PE20121157A1 (es) Compuestos heterociclicos como inhibidores de proteasas serinas
PE20020753A1 (es) Heteroaromaticos fusionados como activadores de la glucoquinasa
NO20031065L (no) Spiroheterocykliske nitriler nyttige som reversible inhibitorer av cysteinproteaser
PE71599A1 (es) Inhibidores de proteasas
DE60034961D1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
AP2001002205A0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
PE20011114A1 (es) Decahidro-isoquinolinas
DE69902754T2 (de) Heteroaryl-amidinen,-methylamidinen und -guanidinen als protease inhibitoren, insbesondere als urokinase inhibitoren
TR200003071T2 (tr) Sistein-proteazı önleyici etkiye sahip yeni heterosiklik ikame edilmiş amidler
PE20001564A1 (es) 1,3-dioxepin-5-ona con un anillo de 7 miembros como inhibidores de proteasas
ATE476434T1 (de) Thienopyridinderivate als kaliumkanalinhibitoren
PE20050483A1 (es) Derivados de tetrazol de formula (i), sus composiciones farmaceuticas y procesos para producir composiciones farmaceuticas
BG105866A (en) Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
DE60005689D1 (de) Neue aminobenzophenone
PE20011374A1 (es) 4-amino-azepan-3-ona como inhibidores de proteasas
AR044175A1 (es) Compuestos de cefemo
PE20001486A1 (es) Compuestos etereos anular de 7 a 14 miembros como inhibidores de proteasas
PE20001355A1 (es) 1,3-diamino-cetonas como inhibidores de proteasas
PE20000725A1 (es) Compuestos de alcoxipirrolidinona como inhibidores de proteasas
PE20001607A1 (es) 4-AMINO-4,5-DIHIDRO-BENZO[b][1,4]DIOXOCIN-3-ONA COMO INHIBIDORES DE PROTEASAS

Legal Events

Date Code Title Description
FD Application declared void or lapsed